Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost Savings on Generic Drugs: Transparent Pric...
By
HEOR Staff Writer
June 18, 2024
Introduction Through its transparent, online direct-to-consumer pharmacy model, the Mark Cuban Cost Plus Drug Company (MCCPDC) has made substantial progress in the provisi...
Brucellosis Control in Armenia: A Holistic Approach
Rethinking Health State Valuation: Moving Beyond ‘Dead’ as an Anchor
Enhancing Clinician Accuracy in EEG Pattern Classification with AI
Advancing Pneumococcal Disease Prevention in Japan with PCV20
Unveiling the Future of Personalised Sleep Medicine
Nurturing Trust in Healthcare: Embracing Generative AI
The Power of Real-World Evidence: Bringing Everyday Health Data to Drug Appro...
Health Technology Assessment in South Africa: Towards NHI
Precision Medicine Competency Framework for the Medical Technology and Pharma...
Balancing the scales: An inclusive framework for equity in Multi-Cancer Early...
The Future of Peer Review in Scientific Manuscripts: Embracing Artificial Int...
How User-Centered Perspectives Foster Innovation in Digital Health Surveillan...
« Previous
1
…
23
24
25
26
27
…
46
Next »